Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma
Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma
Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma
Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies
Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation
MS-553 shows promise in treating chronic lymphocytic leukaemia
Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML
Consolidation treatment delays do not compromise survival in MRD-negative adult ALL
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT
Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL
Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL